CALADRIUS BIOSCIENCES INC - COM NEW (CLBS)

CUSIP: 128058203

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM NEW
Total 13F shares
6,266,135
Share change
-404,076
Total reported value
$10,086,016
Put/Call ratio
64%
Price per share
$1.61
Number of holders
21
Value change
-$855,014
Number of buys
9
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 128058203?
CUSIP 128058203 identifies CLBS - CALADRIUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) as of Q2 2021

As of 30 Jun 2021, CALADRIUS BIOSCIENCES INC - COM NEW (CLBS) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,266,135 shares. The largest 10 holders included VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, CIBC Private Wealth Group, LLC, and GOLDMAN SACHS GROUP INC. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.